Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» Keytruda
Keytruda
Should Merck Investors Worry About Bristol Myers' Lung Cancer Drug Results?
Motley Fool
Mon, 11/4/19 - 10:23 am
Merck
Bristol-Myers Squibb
Yervoy
Opdivo
Keytruda
lung cancer
Bristol-Myers warns I-O blockbuster Opdivo will be 'under pressure' in 2020
Fierce Pharma
Thu, 10/31/19 - 11:52 pm
Bristol-Myers Squibb
Opdivo
Keytruda
Merck
Merck CFO: we’re not only about Keytruda
PM Live
Wed, 10/30/19 - 11:16 pm
Merck
Keytruda
Merck beats estimates as Keytruda sales top $3 billion for first time
Yahoo/Reuters
Tue, 10/29/19 - 09:50 am
Merck
Keytruda
earnings
Merck, BMS, AbbVie blockbusters will rule pharma sales in 2025: report
Fierce Pharma
Fri, 10/4/19 - 12:44 pm
Merck
Keytruda
Bristol-Myers Squibb
Pfizer
Eliquis
AbbVie
Humira
Merck’s KEYTRUDA approved as monotherapy in China for first-line treatment of certain patients with advanced NSCLC
Pharmaceutical Business Review
Thu, 10/3/19 - 10:37 am
Merck
Keytruda
China
non-small cell lung cancer
ESMO: Merck, Eisai detail Keytruda-Lenvima combo results after triple endometrial cancer OK
Fierce Pharma
Sun, 09/29/19 - 09:37 pm
Merck
Eisai
Keytruda
Lenvima
endometrial cancer
ESMO
Merck, Pfizer execs explain how they tap sites for cancer trials
Biopharma Dive
Tue, 09/24/19 - 07:04 pm
cancer
clinical trials
Pfizer
Merck
immuno-oncology
Bavencio
Keytruda
Biotechs Fly Sideways In Quiet Week — 5 News Items You May Have Missed
Investors Business Daily
Sat, 09/21/19 - 12:28 pm
Wave Life Sciences
suvodirsen
DMD
Merck
Keytruda
Biogen
Spinraza
Zoetis
Europe
animal health
Jazz Pharmaceuticals
JZP-258
narcolepsy
The top drugs facing cuts under Pelosi's pricing plan
Biopharma Dive
Fri, 09/20/19 - 10:46 pm
drug pricing
Nancy Pelosi
regulatory
Revlimid
Keytruda
Opdivo
Januvia
insulin
Medicare
Merck, Eisai's Keytruda-Lenvima combo wins simultaneous OKs in U.S., Canada and Australia
Fierce Pharma
Wed, 09/18/19 - 09:56 am
Merck
Keytruda
Eisai
Lenvima
endometrial cancer
Canada
Australia
Esmo 2019 preview – immunotherapies grab the rest of the late-breaker focus
EP Vantage
Tue, 09/10/19 - 11:49 pm
ESMO
Keytruda
Tecentriq
Merck
Roche
WCLC: Merck's Keytruda dispels 'urban legend' with latest lung cancer survival win
Fierce Pharma
Tue, 09/10/19 - 09:30 am
Merck
Keytruda
non-small cell lung cancer
WCLC
At Big Lung Cancer Meeting, Lights Shine on KRAS, Drug Combos & More
Xconomy
Mon, 09/9/19 - 08:08 pm
WCLC
lung cancer
KRAS
AMG 510
Amgen
RET
Merck
Keytruda
AstraZeneca
Imfinzi
Blueprint Medicines
Eli Lilly
WCLC: Merck analyses throw doubt on new biomarker's utility
Fierce Pharma
Mon, 09/9/19 - 09:50 am
Merck
biomarkers
TMB
Keytruda
Keytruda combo cleared as first-line kidney cancer treatment in EU
Pharmaforum
Thu, 09/5/19 - 08:20 pm
Merck
Keytruda
kidney cancer
Europe
Merck’s Keytruda: A Deep Dive
BioSpace
Wed, 08/21/19 - 11:51 pm
Merck
Keytruda
What happened a year ago this week in biopharma? August 12-18, 2018
Mon, 08/19/19 - 11:04 am
Regeneron
Novartis
wet-AMD
Eylea
ethics
Vertex Pharmaceuticals
Kalydeco
cystic fibrosis
Bristol-Myers Squibb
Opdivo
Merck
Keytruda
SCLC
What happened a year ago this week in biopharma? August 12-18, 2018
CP WIre
Sun, 08/18/19 - 04:30 pm
Regeneron
Novartis
wet-AMD
Eylea
ethics
Vertex Pharmaceuticals
Kalydeco
cystic fibrosis
Bristol-Myers Squibb
Opdivo
Merck
Keytruda
SCLC
How Merck Could Ride 'The Keytruda Wave' To Dominate These Rivals
Investors Business Daily
Sat, 08/17/19 - 01:31 pm
Merck
Keytruda
cancer
Pages
« first
‹ previous
…
8
9
10
11
12
13
14
15
16
…
next ›
last »